Recommendations Updated for Recombinant Zoster Vaccine
THURSDAY, Jan. 20, 2022 (HealthDay News) -- Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged 19 years and older; the recommendations are available in the Jan. 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Tara C. Anderson, D.V.M., Ph.D., from the CDC in Atlanta, and colleagues present the recommendations of the Advisory Committee on Immunization Practices (ACIP) for RZV.
The researchers note that on July 23, 2021, the U.S. Food and Drug Administration expanded the indication for RZV to include adults aged 18 years and older who are or will be at increased risk for herpes zoster due to immunodeficiency or immunosuppression caused by known disease or therapy. For adults aged 19 years and older who are or will be immunodeficient or immunosuppressed due to disease or therapy, the ACIP recommended two doses of RZV for prevention of herpes zoster and related complications. RZV is the first herpes zoster vaccine approved for immunocompromised individuals and has moderate-to-high vaccine efficacy and an acceptable safety profile.
"RZV has the potential to prevent considerable herpes zoster incidence and related complications," the authors write. "Recommending vaccination of immunocompromised adults aged ≥19 years will enable providers to vaccinate patients at a time most appropriate for their immunocompromising condition or therapy."
One author disclosed financial ties to the pharmaceutical and medical technology industries.
Related Posts
Routine Ventilation of Surgical Patients Won’t Raise COVID Transmission Risk
WEDNESDAY, Oct. 27, 2021 (HealthDay News) -- Routine face mask ventilation...
Es demasiado pronto para saber si la ómicron acabará con la pandemia, según Fauci
MARTES, 18 de enero de 2022 (HealthDay News) -- Es demasiado pronto para...
Drug Might Help Slow Nearsightedness in Kids
FRIDAY, June 2, 2023 (HealthDay News) -- There is no cure for nearsightedness,...
AHA News: Stroke Survivor Never Lost Fluency in the Language of Dance, Art and Song
FRIDAY, March 11, 2022 (American Heart Association News) -- When Paula Gallagher...